[1]
Bhardwaj, R.K. 2013. A Comparative study of Rosuvastatin and Fenofibrate as Monotherapy in Dyslipidemia and NCEP ATP III Goals. Journal of Drug Delivery and Therapeutics. 3, 4 (Jul. 2013), 108–113. DOI:https://doi.org/10.22270/jddt.v3i4.583.